S&P 500   3,980.35 (+0.01%)
DOW   31,580.63 (+0.00%)
QQQ   298.28 (-0.23%)
AAPL   154.98 (-0.63%)
MSFT   257.48 (-0.24%)
META   160.78 (+0.24%)
GOOGL   108.61 (-0.77%)
AMZN   128.61 (-0.67%)
TSLA   285.79 (+0.74%)
NVDA   137.72 (+0.42%)
NIO   17.46 (-0.11%)
BABA   89.07 (-1.69%)
AMD   81.92 (+2.90%)
T   16.84 (-0.18%)
MU   54.54 (-0.84%)
CGC   3.40 (-0.29%)
F   15.18 (-1.62%)
GE   73.24 (-0.46%)
DIS   111.64 (-0.93%)
AMC   8.49 (+1.19%)
PYPL   95.41 (+0.46%)
PFE   46.55 (+0.91%)
NFLX   225.32 (-1.59%)
S&P 500   3,980.35 (+0.01%)
DOW   31,580.63 (+0.00%)
QQQ   298.28 (-0.23%)
AAPL   154.98 (-0.63%)
MSFT   257.48 (-0.24%)
META   160.78 (+0.24%)
GOOGL   108.61 (-0.77%)
AMZN   128.61 (-0.67%)
TSLA   285.79 (+0.74%)
NVDA   137.72 (+0.42%)
NIO   17.46 (-0.11%)
BABA   89.07 (-1.69%)
AMD   81.92 (+2.90%)
T   16.84 (-0.18%)
MU   54.54 (-0.84%)
CGC   3.40 (-0.29%)
F   15.18 (-1.62%)
GE   73.24 (-0.46%)
DIS   111.64 (-0.93%)
AMC   8.49 (+1.19%)
PYPL   95.41 (+0.46%)
PFE   46.55 (+0.91%)
NFLX   225.32 (-1.59%)
S&P 500   3,980.35 (+0.01%)
DOW   31,580.63 (+0.00%)
QQQ   298.28 (-0.23%)
AAPL   154.98 (-0.63%)
MSFT   257.48 (-0.24%)
META   160.78 (+0.24%)
GOOGL   108.61 (-0.77%)
AMZN   128.61 (-0.67%)
TSLA   285.79 (+0.74%)
NVDA   137.72 (+0.42%)
NIO   17.46 (-0.11%)
BABA   89.07 (-1.69%)
AMD   81.92 (+2.90%)
T   16.84 (-0.18%)
MU   54.54 (-0.84%)
CGC   3.40 (-0.29%)
F   15.18 (-1.62%)
GE   73.24 (-0.46%)
DIS   111.64 (-0.93%)
AMC   8.49 (+1.19%)
PYPL   95.41 (+0.46%)
PFE   46.55 (+0.91%)
NFLX   225.32 (-1.59%)
S&P 500   3,980.35 (+0.01%)
DOW   31,580.63 (+0.00%)
QQQ   298.28 (-0.23%)
AAPL   154.98 (-0.63%)
MSFT   257.48 (-0.24%)
META   160.78 (+0.24%)
GOOGL   108.61 (-0.77%)
AMZN   128.61 (-0.67%)
TSLA   285.79 (+0.74%)
NVDA   137.72 (+0.42%)
NIO   17.46 (-0.11%)
BABA   89.07 (-1.69%)
AMD   81.92 (+2.90%)
T   16.84 (-0.18%)
MU   54.54 (-0.84%)
CGC   3.40 (-0.29%)
F   15.18 (-1.62%)
GE   73.24 (-0.46%)
DIS   111.64 (-0.93%)
AMC   8.49 (+1.19%)
PYPL   95.41 (+0.46%)
PFE   46.55 (+0.91%)
NFLX   225.32 (-1.59%)
NASDAQ:CGC

Canopy Growth - CGC Stock Forecast, Price & News

$3.40
-0.01 (-0.29%)
(As of 09/8/2022 10:16 AM ET)
Add
Compare
Today's Range
$3.35
$3.49
50-Day Range
$2.24
$4.23
52-Week Range
$2.13
$16.83
Volume
46,442 shs
Average Volume
13.57 million shs
Market Capitalization
$1.63 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.51

Canopy Growth MarketRank™ Forecast

Analyst Rating
Hold
1.59 Rating Score
Upside/​Downside
148.8% Upside
$8.51 Price Target
Short Interest
Healthy
8.50% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.83
Upright™ Environmental Score
News Sentiment
1.30mentions of Canopy Growth in the last 14 days
Based on 4 Articles This Week
Insider Trading
Selling Shares
$6,484 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.91) to ($0.44) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.92 out of 5 stars

Medical Sector

752nd out of 1,091 stocks

Medicinals & Botanicals Industry

10th out of 15 stocks

CGC stock logo

About Canopy Growth (NASDAQ:CGC) Stock

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.

Receive CGC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Canopy Growth and its competitors with MarketBeat's FREE daily newsletter.

CGC Stock News Headlines

This Is Canopy Growth's Must-Hold Support Level
Canopy Growth (NASDAQ:CGC) Shares Down 5.2%
Canopy Growth swings to big loss as revenue falls 19%
Updated Canopy Growth Corporation ($CGC) 4H Forecast
See More Headlines
Receive CGC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Canopy Growth and its competitors with MarketBeat's FREE daily newsletter.

CGC Company Calendar

Last Earnings
8/05/2022
Today
9/08/2022
Next Earnings (Estimated)
11/04/2022
Fiscal Year End
3/31/2023

Industry, Sector and Symbol

Industry
Medicinals & botanicals
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:CGC
Fax
N/A
Employees
3,151
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$8.51
High Stock Price Forecast
$21.60
Low Stock Price Forecast
$2.33
Forecasted Upside/Downside
+150.3%
Consensus Rating
Hold
Rating Score (0-4)
1.59
Research Coverage
17 Analysts

Profitability

Net Income
$-241,080,000.00
Net Margins
-558.27%
Pretax Margin
-566.80%

Debt

Sales & Book Value

Annual Sales
$415.09 million
Cash Flow
$0.67 per share
Book Value
$7.27 per share

Miscellaneous

Free Float
479,019,000
Market Cap
$1.63 billion
Optionable
Optionable
Beta
1.85

Key Executives

  • Mr. David Eric Klein (Age 58)
    CEO & Director
    Comp: $2.79M
  • Mr. Julious C. Grant Jr. (Age 54)
    Chief Commercial Officer
    Comp: $686.07k
  • Ms. Judy Eunjoo Hong (Age 49)
    VP of Investor Relations & Competitive Intelligence, Chief of Staff to the CEO and CFO
  • Mr. Jonathan Di Tosto
    Chief Operations Officer
  • Mr. Thomas Carlton Stewart (Age 40)
    VP & Chief Accounting Officer
  • Mr. Thomas Shipley IV (Age 33)
    Sr. VP of Quality Assurance & Chief Science Officer
  • Ms. Holly Lukavsky
    Chief HR Officer
  • Mr. Timothy Rob Saunders F.C.A. (Age 61)
    FCPA, Strategic Advisor
  • Jason Green
    Head of Agriculture - Hemp Division
  • Dr. Mark A. Ware
    Chief Medical Officer













CGC Stock - Frequently Asked Questions

Should I buy or sell Canopy Growth stock right now?

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Canopy Growth in the last year. There are currently 9 sell ratings, 6 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" CGC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CGC, but not buy additional shares or sell existing shares.
View CGC analyst ratings
or view top-rated stocks.

What is Canopy Growth's stock price forecast for 2022?

17 brokerages have issued 1-year price targets for Canopy Growth's stock. Their CGC share price forecasts range from $2.33 to $21.60. On average, they expect the company's share price to reach $8.51 in the next year. This suggests a possible upside of 150.3% from the stock's current price.
View analysts price targets for CGC
or view top-rated stocks among Wall Street analysts.

How have CGC shares performed in 2022?

Canopy Growth's stock was trading at $8.73 on January 1st, 2022. Since then, CGC shares have decreased by 61.1% and is now trading at $3.40.
View the best growth stocks for 2022 here
.

When is Canopy Growth's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, November 4th 2022.
View our CGC earnings forecast
.

How were Canopy Growth's earnings last quarter?

Canopy Growth Co. (NASDAQ:CGC) announced its earnings results on Friday, August, 5th. The company reported ($5.23) EPS for the quarter, missing the consensus estimate of ($0.28) by $4.95. The business earned $122.90 million during the quarter, compared to analyst estimates of $113.45 million. Canopy Growth had a negative net margin of 558.27% and a negative trailing twelve-month return on equity of 25.21%. The company's revenue was down 9.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted ($0.13) EPS.

What is Canopy Growth's stock symbol?

Canopy Growth trades on the NASDAQ under the ticker symbol "CGC."

Who are Canopy Growth's major shareholders?

Canopy Growth's stock is owned by many different institutional and retail investors. Top institutional investors include Pura Vida Investments LLC (0.00%), Citadel Advisors LLC (0.00%), Mirae Asset Global Investments Co. Ltd. (0.18%), Goldman Sachs Group Inc. (0.00%), TD Asset Management Inc. (0.14%) and AdvisorShares Investments LLC (0.13%). Insiders that own company stock include Judy Eun Joo Hong, Phillip Stephen Shaer, Rade Nikola Kovacevic, Thomas Carlton Stewart and Tomas Iv Shipley.
View institutional ownership trends
.

How do I buy shares of Canopy Growth?

Shares of CGC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Canopy Growth's stock price today?

One share of CGC stock can currently be purchased for approximately $3.40.

How much money does Canopy Growth make?

Canopy Growth (NASDAQ:CGC) has a market capitalization of $1.63 billion and generates $415.09 million in revenue each year. The company earns $-241,080,000.00 in net income (profit) each year or ($5.49) on an earnings per share basis.

How many employees does Canopy Growth have?

The company employs 3,151 workers across the globe.

How can I contact Canopy Growth?

Canopy Growth's mailing address is 1 HERSHEY DRIVE, SMITH FALLS A6, K7A0A8. The official website for the company is www.canopygrowth.com. The company can be reached via phone at (855) 558-9333 or via email at invest@canopygrowth.com.

This page (NASDAQ:CGC) was last updated on 9/8/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.